Speech-Language Pathologists in Dumfries, VA Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Josiah Hutchings, M.A.,CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2500 River Heritage Blvd, Dumfries, VA 22026 Phone: 571-466-4500

Above And Beyond Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15389 Autum Ln, Dumfries, VA 22025 Phone: 703-496-4198

Rebecca Bevins Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 16125 Dumfries Rd, Dumfries, VA 22025 Phone: 703-670-3173

Amanda Lynn Mafrici, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16125 Dumfries Rd, Dumfries, VA 22025 Phone: 412-952-3390

Alana Difilippo Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2500 River Heritage Blvd, Dumfries, VA 22026 Phone: 571-466-4500

News Archive

Dementia patients allowed to live at home thanks to new research program

A Johns Hopkins research program that brought resources and counselors to elderly Baltimore residents with memory disorders such as dementia significantly increased the chance they could continue to live successfully at home, a preference for most of them.

Active outreach may enhance kids' ability to get health insurance

A new review of existing research suggests that health system workers can boost the number of children with medical insurance by providing application materials to parents and helping them fill out the forms.

Two experimental drugs aimed at controlling viral loads among HIV-positive people who have developed drug resistance show promise

Two experimental antiretroviral drugs, called TMC278 and elvitegravir, show promise in controlling the viral loads of HIV-positive people who have developed resistance to available drugs, researchers said Wednesday at the 14th Annual Conference on Retroviruses and Opportunistic Infections in Los Angeles, the Los Angeles Times reports.

Hillenbrand third-quarter 2010 revenue increases 30% to $205.8 million

Hillenbrand reported third quarter 2010 revenue of $205.8 million, a $47.1 million (30 percent) increase over the prior year, due primarily to the inclusion of revenue generated by K-Tron International, which Hillenbrand acquired April 1, 2010. Business acquisition costs and the impact of purchase accounting were the primary drivers of a $12.1 million (48 percent) decrease in net income from the prior year and a $0.19 (46 percent) decrease in earnings per share, from $0.41 to $0.22.

Fleming ramps up production of ThyroShield to meet increased domestic and international demand

Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.

Read more Medical News

› Verified 1 days ago